Up to 30% of patients with diarrheal irritable bowel syndrome also suffer from bile acid malabsorption (BAM). Recently a new test was introduced that can identify bile acid malabsorption from a stool sample. BAM alone can cause ileal dysfunction and impaired reabsorption, as well as complicate other gastrointestinal disorders. Treatment for BAM without identification of increased bile acids can result in adverse side effects. With the introduction of this new test, it is now possible to identify BAM in patients before initiating treatment.
A presentation by Leslie Donato, PhD.